• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 3. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 4. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 5. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651

• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Tropane alkaloids Tropane alkaloids
• Solvents and Organic Chemicals Organic Compounds Alkaloids and derivatives Tropane alkaloids
• Natural Products and Extracts Plant Extracts Plant based Anthocercis ilicifolia

Comprehensive Analysis of Benzenepropanoic acid, a-hydroxy-,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (aR)- (CAS No. 21956-47-8)

The compound Benzenepropanoic acid, a-hydroxy-,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (aR)- (CAS No. 21956-47-8) is a structurally complex molecule that has garnered significant attention in pharmaceutical and biochemical research. Its unique 8-azabicyclo[3.2.1]octane scaffold and ester linkage make it a subject of interest for drug development, particularly in targeting neurological and metabolic pathways. Researchers are increasingly exploring its potential as a precursor for novel therapeutics, aligning with the growing demand for innovative small-molecule drugs.

One of the key features of Benzenepropanoic acid, a-hydroxy-,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (aR)- is its stereospecific configuration, denoted by the (aR)- descriptor. This chiral center plays a critical role in its biological activity, as enantiopure compounds often exhibit higher efficacy and fewer side effects. This aligns with current trends in precision medicine, where chiral synthesis and stereoselective catalysis are hot topics in organic chemistry. The compound’s a-hydroxy group further enhances its reactivity, making it a versatile intermediate for derivatization.

In the context of drug discovery, the 8-methyl-8-azabicyclo[3.2.1]octane moiety is particularly noteworthy. This bicyclic structure is reminiscent of tropane alkaloids, which are known for their pharmacological properties. As such, CAS No. 21956-47-8 is often studied for its potential interactions with neurotransmitter receptors, a topic of high relevance given the rising prevalence of neurological disorders. Searches for "neuroactive small molecules" and "tropane derivatives" have surged in recent years, reflecting the scientific community’s interest in this area.

The ester linkage in Benzenepropanoic acid, a-hydroxy-,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (aR)- also opens doors for prodrug applications. Prodrugs are a major focus in modern pharmacology, as they improve bioavailability and reduce toxicity. This compound’s ability to undergo enzymatic hydrolysis in vivo could make it a candidate for sustained-release formulations, a frequently searched term in pharmaceutical forums. Additionally, its benzenepropanoic acid backbone is structurally similar to nonsteroidal anti-inflammatory drugs (NSAIDs), hinting at potential anti-inflammatory properties.

From a synthetic chemistry perspective, the preparation of CAS No. 21956-47-8 involves sophisticated techniques such as asymmetric synthesis and ring-closing metathesis. These methods are widely discussed in academic circles, with many researchers seeking information on "efficient bicyclic compound synthesis" and "chiral esterification protocols." The compound’s complexity also makes it a valuable case study for advanced NMR and mass spectrometry characterization, techniques that are essential for quality control in drug manufacturing.

Environmental and regulatory considerations are another angle of interest. While Benzenepropanoic acid, a-hydroxy-,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (aR)- is not classified as hazardous, its biodegradation pathways and ecotoxicological profile are subjects of ongoing research. Queries like "green chemistry approaches for complex esters" and "biodegradable pharmaceutical intermediates" are increasingly common, reflecting a shift toward sustainable practices in chemical synthesis.

In summary, Benzenepropanoic acid, a-hydroxy-,(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (aR)- (CAS No. 21956-47-8) represents a multifaceted compound with broad applications in medicinal chemistry and drug development. Its unique structure, combined with current scientific trends, positions it as a valuable subject for further investigation. Whether for neurological research, prodrug design, or sustainable synthesis, this molecule continues to captivate researchers and industry professionals alike.

• 456-59-7(Cyclandelate)
• 51-34-3(Scopolamine)
• 55-48-1(Atropine sulfate)
• 51-55-8(Atropine)
• 101-31-5(L-Hyoscyamine)
• 77-23-6(pentoxyverine)
• 87-00-3((1R,3R,5S)-8-methyl-8-azabicyclo3.2.1octan-3-yl 2-hydroxy-2-phenylacetate)
• 132-17-2(Benztropine mesylate)
• 121-39-1(Ethyl 3-phenylglycidate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)